+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cancer/Tumor Profiling - Market Analysis, Trends, and Forecasts

  • ID: 4804691
  • Report
  • 193 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Caris Life Sciences
  • Genomic Health
  • Helomics
  • Htg Molecular Diagnostics
  • Illumina
  • Nanostring Technologies
  • MORE
Cancer/Tumor Profiling market worldwide is projected to grow by US$5.6 Billion, driven by a compounded growth of 10.4%. Immunoassays, one of the segments analyzed and sized in this study, displays the potential to grow at over 10.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$3.5 Billion by the year 2025, Immunoassays will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$251.8 Million to the region's size and clout in the next 5 to 6 years. Over US$259.5 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Immunoassays will reach a market size of US$319 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9.9% over the next couple of years and add approximately US$952.3 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Caris Life Sciences
  • Genomic Health, Inc.
  • Helomics® Corporation
  • HTG Molecular Diagnostics, Inc.
  • Illumina, Inc.
  • Nanostring Technologies, Inc.
  • NeoGenomics Laboratories, Inc.
  • Oxford Gene Technology
  • Qiagen NV
  • Ribomed Biotechnologies, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Caris Life Sciences
  • Genomic Health
  • Helomics
  • Htg Molecular Diagnostics
  • Illumina
  • Nanostring Technologies
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Cancer/Tumor Profiling Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Cancer/Tumor Profiling Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Cancer/Tumor Profiling Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Cancer/Tumor Profiling Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Immunoassays (Technology) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Immunoassays (Technology) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Immunoassays (Technology) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Hybridization (Technology) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Hybridization (Technology) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Hybridization (Technology) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Next Generation Sequencing (Technology) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Next Generation Sequencing (Technology) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Next Generation Sequencing (Technology) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Mass Spectrometry (Technology) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 14: Mass Spectrometry (Technology) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 15: Mass Spectrometry (Technology) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Other Technologies (Technology) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 17: Other Technologies (Technology) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 18: Other Technologies (Technology) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 19: Breast Cancer (Cancer Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025

TABLE 20: Breast Cancer (Cancer Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 21: Breast Cancer (Cancer Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

TABLE 22: Lung Cancer (Cancer Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025

TABLE 23: Lung Cancer (Cancer Type) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017

TABLE 24: Lung Cancer (Cancer Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 25: Colorectal Cancer (Cancer Type) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 26: Colorectal Cancer (Cancer Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 27: Colorectal Cancer (Cancer Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 28: Prostate Cancer (Cancer Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 29: Prostate Cancer (Cancer Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 30: Prostate Cancer (Cancer Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 31: Melanoma Cancer (Cancer Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 32: Melanoma Cancer (Cancer Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 33: Melanoma Cancer (Cancer Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 34: Other Cancer Types (Cancer Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 35: Other Cancer Types (Cancer Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 36: Other Cancer Types (Cancer Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 37: Clinical Application (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025

TABLE 38: Clinical Application (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017

TABLE 39: Clinical Application (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025

TABLE 40: Research Application (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025

TABLE 41: Research Application (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017

TABLE 42: Research Application (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Cancer/Tumor Profiling Market Share (in %) by Company: 2019 & 2025

TABLE 43: Cancer/Tumor Profiling Market in US$ Million in the United States by Technology: 2018-2025

TABLE 44: United States Cancer/Tumor Profiling Market Retrospective Analysis in US$ Million by Technology: 2009-2017

TABLE 45: United States Cancer/Tumor Profiling Market Share Breakdown by Technology: 2009 VS 2019 VS 2025

TABLE 46: United States Cancer/Tumor Profiling Market Estimates and Projections in US$ Million by Cancer Type: 2018 to 2025

TABLE 47: Cancer/Tumor Profiling Market in the United States by Cancer Type: A Historic Review in US$ Million for 2009-2017

TABLE 48: United States Cancer/Tumor Profiling Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025

TABLE 49: United States Cancer/Tumor Profiling Latent Demand Forecasts in US$ Million by Application: 2018 to 2025

TABLE 50: Cancer/Tumor Profiling Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017

TABLE 51: Cancer/Tumor Profiling Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025

CANADA

TABLE 52: Cancer/Tumor Profiling Market Analysis in Canada in US$ Million by Technology: 2018-2025

TABLE 53: Cancer/Tumor Profiling Market in Canada: Historic Review in US$ Million by Technology for the Period 2009-2017

TABLE 54: Canadian Cancer/Tumor Profiling Market Share Breakdown by Technology: 2009 VS 2019 VS 2025

TABLE 55: Canadian Cancer/Tumor Profiling Market Estimates and Forecasts in US$ Million by Cancer Type: 2018 to 2025

TABLE 56: Canadian Cancer/Tumor Profiling Historic Market Review by Cancer Type in US$ Million: 2009-2017

TABLE 57: Cancer/Tumor Profiling Market in Canada: Percentage Share Breakdown of Sales by Cancer Type for 2009, 2019, and 2025

TABLE 58: Canadian Cancer/Tumor Profiling Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025

TABLE 59: Cancer/Tumor Profiling Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017

TABLE 60: Canadian Cancer/Tumor Profiling Market Share Analysis by Application: 2009 VS 2019 VS 2025

JAPAN

TABLE 61: Japanese Medium & Long-Term Outlook for Cancer/Tumor Profiling Market in US$ Million by Technology: 2018-2025

TABLE 62: Cancer/Tumor Profiling Market in Japan in US$ Million by Technology: 2009-2017

TABLE 63: Japanese Cancer/Tumor Profiling Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025

TABLE 64: Japanese Market for Cancer/Tumor Profiling: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the Period 2018-2025

TABLE 65: Cancer/Tumor Profiling Market in Japan: Historic Sales Analysis in US$ Million by Cancer Type for the Period 2009-2017

TABLE 66: Japanese Cancer/Tumor Profiling Market Share Analysis by Cancer Type: 2009 VS 2019 VS 2025

TABLE 67: Japanese Demand Estimates and Forecasts for Cancer/Tumor Profiling in US$ Million by Application: 2018 to 2025

TABLE 68: Japanese Cancer/Tumor Profiling Market in US$ Million by Application: 2009-2017

TABLE 69: Cancer/Tumor Profiling Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025

CHINA

TABLE 70: Cancer/Tumor Profiling Market Estimates and Forecasts in China in US$ Million by Technology: 2018-2025

TABLE 71: Chinese Cancer/Tumor Profiling Retrospective Market Scenario in US$ Million by Technology: 2009-2017

TABLE 72: Cancer/Tumor Profiling Market in China: Percentage Share Analysis by Technology for 2009, 2019, and 2025

TABLE 73: Chinese Cancer/Tumor Profiling Market Growth Prospects in US$ Million by Cancer Type for the Period 2018-2025

TABLE 74: Cancer/Tumor Profiling Historic Market Analysis in China in US$ Million by Cancer Type: 2009-2017

TABLE 75: Chinese Cancer/Tumor Profiling Market by Cancer Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 76: Chinese Demand for Cancer/Tumor Profiling in US$ Million by Application: 2018 to 2025

TABLE 77: Cancer/Tumor Profiling Market Review in China in US$ Million by Application: 2009-2017

TABLE 78: Chinese Cancer/Tumor Profiling Market Share Breakdown by Application: 2009 VS 2019 VS 2025

EUROPE

Market Facts & Figures

European Cancer/Tumor Profiling Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 79: European Cancer/Tumor Profiling Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 80: Cancer/Tumor Profiling Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 81: European Cancer/Tumor Profiling Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 82: European Cancer/Tumor Profiling Market Assessment in US$ Million by Technology: 2018-2025

TABLE 83: European Cancer/Tumor Profiling Historic Market Review in US$ Million by Technology: 2009-2017

TABLE 84: Cancer/Tumor Profiling Market in Europe: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025

TABLE 85: European Cancer/Tumor Profiling Market Estimates and Forecasts in US$ Million by Cancer Type: 2018-2025

TABLE 86: Cancer/Tumor Profiling Market in Europe in US$ Million by Cancer Type: A Historic Review for the Period 2009-2017

TABLE 87: European Cancer/Tumor Profiling Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025

TABLE 88: European Cancer/Tumor Profiling Addressable Market Opportunity in US$ Million by Application: 2018-2025

TABLE 89: Cancer/Tumor Profiling Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017

TABLE 90: European Cancer/Tumor Profiling Market Share Analysis by Application: 2009 VS 2019 VS 2025

FRANCE

TABLE 91: French Cancer/Tumor Profiling Market Estimates and Projections in US$ Million by Technology: 2018-2025

TABLE 92: French Cancer/Tumor Profiling Historic Market Analysis in US$ Million by Technology: 2009-2017

TABLE 93: French Cancer/Tumor Profiling Market Share Breakdown by Technology: 2009 VS 2019 VS 2025

TABLE 94: Cancer/Tumor Profiling Market in France by Cancer Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 95: French Cancer/Tumor Profiling Historic Market Scenario in US$ Million by Cancer Type: 2009-2017

TABLE 96: French Cancer/Tumor Profiling Market Share Analysis by Cancer Type: 2009 VS 2019 VS 2025

TABLE 97: Cancer/Tumor Profiling Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025

TABLE 98: French Cancer/Tumor Profiling Historic Market Review in US$ Million by Application: 2009-2017

TABLE 99: French Cancer/Tumor Profiling Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025

GERMANY

TABLE 100: German Cancer/Tumor Profiling Latent Demand Forecasts in US$ Million by Technology: 2018-2025

TABLE 101: Cancer/Tumor Profiling Market in Germany: A Historic Perspective by Technology in US$ Million for the Period 2009-2017

TABLE 102: German Cancer/Tumor Profiling Market Share Breakdown by Technology: 2009 VS 2019 VS 2025

TABLE 103: Cancer/Tumor Profiling Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Cancer Type for the Period 2018-2025

TABLE 104: German Cancer/Tumor Profiling Historic Market Analysis in US$ Million by Cancer Type: 2009-2017

TABLE 105: German Cancer/Tumor Profiling Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025

TABLE 106: Cancer/Tumor Profiling Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025

TABLE 107: German Cancer/Tumor Profiling Market in Retrospect in US$ Million by Application: 2009-2017

TABLE 108: Cancer/Tumor Profiling Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025

ITALY

TABLE 109: Cancer/Tumor Profiling Market Estimates and Forecasts in Italy in US$ Million by Technology: 2018-2025

TABLE 110: Italian Cancer/Tumor Profiling Retrospective Market Scenario in US$ Million by Technology: 2009-2017

TABLE 111: Cancer/Tumor Profiling Market in Italy: Percentage Share Analysis by Technology for 2009, 2019, and 2025

TABLE 112: Italian Cancer/Tumor Profiling Market Growth Prospects in US$ Million by Cancer Type for the Period 2018-2025

TABLE 113: Cancer/Tumor Profiling Historic Market Analysis in Italy in US$ Million by Cancer Type: 2009-2017

TABLE 114: Italian Cancer/Tumor Profiling Market by Cancer Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 115: Italian Demand for Cancer/Tumor Profiling in US$ Million by Application: 2018 to 2025

TABLE 116: Cancer/Tumor Profiling Market Review in Italy in US$ Million by Application: 2009-2017

TABLE 117: Italian Cancer/Tumor Profiling Market Share Breakdown by Application: 2009 VS 2019 VS 2025

UNITED KINGDOM

TABLE 118: United Kingdom Medium & Long-Term Outlook for Cancer/Tumor Profiling Market in US$ Million by Technology: 2018-2025

TABLE 119: Cancer/Tumor Profiling Market in the United Kingdom in US$ Million by Technology: 2009-2017

TABLE 120: United Kingdom Cancer/Tumor Profiling Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025

TABLE 121: United Kingdom Market for Cancer/Tumor Profiling: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the Period 2018-2025

TABLE 122: Cancer/Tumor Profiling Market in the United Kingdom: Historic Sales Analysis in US$ Million by Cancer Type for the Period 2009-2017

TABLE 123: United Kingdom Cancer/Tumor Profiling Market Share Analysis by Cancer Type: 2009 VS 2019 VS 2025

TABLE 124: United Kingdom Demand Estimates and Forecasts for Cancer/Tumor Profiling in US$ Million by Application: 2018 to 2025

TABLE 125: United Kingdom Cancer/Tumor Profiling Market in US$ Million by Application: 2009-2017

TABLE 126: Cancer/Tumor Profiling Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 127: Rest of Europe Cancer/Tumor Profiling Market Assessment in US$ Million by Technology: 2018-2025

TABLE 128: Rest of Europe Cancer/Tumor Profiling Historic Market Review in US$ Million by Technology: 2009-2017

TABLE 129: Cancer/Tumor Profiling Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025

TABLE 130: Rest of Europe Cancer/Tumor Profiling Market Estimates and Forecasts in US$ Million by Cancer Type: 2018-2025

TABLE 131: Cancer/Tumor Profiling Market in Rest of Europe in US$ Million by Cancer Type: A Historic Review for the Period 2009-2017

TABLE 132: Rest of Europe Cancer/Tumor Profiling Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025

TABLE 133: Rest of Europe Cancer/Tumor Profiling Addressable Market Opportunity in US$ Million by Application: 2018-2025

TABLE 134: Cancer/Tumor Profiling Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017

TABLE 135: Rest of Europe Cancer/Tumor Profiling Market Share Analysis by Application: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 136: Asia-Pacific Cancer/Tumor Profiling Market Estimates and Projections in US$ Million by Technology: 2018-2025

TABLE 137: Asia-Pacific Cancer/Tumor Profiling Historic Market Analysis in US$ Million by Technology: 2009-2017

TABLE 138: Asia-Pacific Cancer/Tumor Profiling Market Share Breakdown by Technology: 2009 VS 2019 VS 2025

TABLE 139: Cancer/Tumor Profiling Market in Asia-Pacific by Cancer Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 140: Asia-Pacific Cancer/Tumor Profiling Historic Market Scenario in US$ Million by Cancer Type: 2009-2017

TABLE 141: Asia-Pacific Cancer/Tumor Profiling Market Share Analysis by Cancer Type: 2009 VS 2019 VS 2025

TABLE 142: Cancer/Tumor Profiling Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025

TABLE 143: Asia-Pacific Cancer/Tumor Profiling Historic Market Review in US$ Million by Application: 2009-2017

TABLE 144: Asia-Pacific Cancer/Tumor Profiling Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025

REST OF WORLD

TABLE 145: Cancer/Tumor Profiling Market Analysis in Rest of World in US$ Million by Technology: 2018-2025

TABLE 146: Cancer/Tumor Profiling Market in Rest of World: Historic Review in US$ Million by Technology for the Period 2009-2017

TABLE 147: Rest of World Cancer/Tumor Profiling Market Share Breakdown by Technology: 2009 VS 2019 VS 2025

TABLE 148: Rest of World Cancer/Tumor Profiling Market Estimates and Forecasts in US$ Million by Cancer Type: 2018 to 2025

TABLE 149: Rest of World Cancer/Tumor Profiling Historic Market Review by Cancer Type in US$ Million: 2009-2017

TABLE 150: Cancer/Tumor Profiling Market in Rest of World: Percentage Share Breakdown of Sales by Cancer Type for 2009, 2019, and 2025

TABLE 151: Rest of World Cancer/Tumor Profiling Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025

TABLE 152: Cancer/Tumor Profiling Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017

TABLE 153: Rest of World Cancer/Tumor Profiling Market Share Analysis by Application: 2009 VS 2019 VS 2025

IV. COMPETITION

CARIS LIFE SCIENCES

GENOMIC HEALTH

HTG MOLECULAR DIAGNOSTICS

HELOMICS

ILLUMINA

NANOSTRING TECHNOLOGIES

NEOGENOMICS LABORATORIES

OXFORD GENE TECHNOLOGY

QIAGEN NV

RIBOMED BIOTECHNOLOGIES, INC.

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Caris Life Sciences
  • Genomic Health
  • Htg Molecular Diagnostics
  • Helomics
  • Illumina
  • Nanostring Technologies
  • Neogenomics Laboratories
  • Oxford Gene Technology
  • Qiagen Nv
  • Ribomed Biotechnologies, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll